Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Harper

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|November 6, 2023
Tuning the potency and selectivity of ImmTAC molecules by affinity modulationIan B Robertson, Rachel Mulvaney, Nele Dieckmann, et al.
The Journal of Biological Chemistry|June 14, 2020
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4Charlotte H Coles, Catriona McMurran, Angharad Lloyd, et al.
Military Medicine|May 31, 2025
Medical Direction Needs Analysis: Codifying a Medical Directors Course to Meet the Demands of Modern Combat CareJoshua Lowe, Eric Kretz, Emily Raetz, et al.
Scientific Reports|November 5, 2024
Broadening alloselectivity of T cell receptors by structure guided engineeringVijaykumar Karuppiah, Dhaval Sangani, Lorraine Whaley, et al.
Molecular Therapy Oncolytics|September 11, 2020
Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for ImmunotherapyRory M Crean, Bruce J MacLachlan, Florian Madura, et al.
Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.
Cell Host & Microbe|November 29, 2024
Protection against Clostridioides difficile disease by a naturally avirulent strainQiwen Dong, Stephen Harper, Emma McSpadden, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Protection against <i>Clostridioides difficile</i> disease by a naturally avirulent <i>C. difficile</i> strainQiwen Dong, Stephen Harper, Emma McSpadden, et al.
Nature Communications|September 10, 2022
Therapeutic high affinity T cell receptor targeting a KRAS<sup>G12D</sup> cancer neoantigenAndrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2020
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA ComplexCharlotte H Coles, Rachel M Mulvaney, Sunir Malla, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|November 6, 2023
Tuning the potency and selectivity of ImmTAC molecules by affinity modulationIan B Robertson, Rachel Mulvaney, Nele Dieckmann, et al.
The Journal of Biological Chemistry|June 14, 2020
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4Charlotte H Coles, Catriona McMurran, Angharad Lloyd, et al.
Military Medicine|May 31, 2025
Medical Direction Needs Analysis: Codifying a Medical Directors Course to Meet the Demands of Modern Combat CareJoshua Lowe, Eric Kretz, Emily Raetz, et al.
Scientific Reports|November 5, 2024
Broadening alloselectivity of T cell receptors by structure guided engineeringVijaykumar Karuppiah, Dhaval Sangani, Lorraine Whaley, et al.
Molecular Therapy Oncolytics|September 11, 2020
Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for ImmunotherapyRory M Crean, Bruce J MacLachlan, Florian Madura, et al.
Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.
Cell Host & Microbe|November 29, 2024
Protection against Clostridioides difficile disease by a naturally avirulent strainQiwen Dong, Stephen Harper, Emma McSpadden, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Protection against <i>Clostridioides difficile</i> disease by a naturally avirulent <i>C. difficile</i> strainQiwen Dong, Stephen Harper, Emma McSpadden, et al.
Nature Communications|September 10, 2022
Therapeutic high affinity T cell receptor targeting a KRAS<sup>G12D</sup> cancer neoantigenAndrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2020
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA ComplexCharlotte H Coles, Rachel M Mulvaney, Sunir Malla, et al.
Pageof 4